ThursdayJul 18, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction

Clene plans to submit a briefing book to the U.S. Food and Drug Administration by July 13 as Part of Overall Process to Support Approval for CNM-Au8(R) for Treatment of ALS Type C interaction is aimed at obtaining FDA feedback on the potential pathway for a new drug application for CNM-Au8 as a treatment for ALS via the accelerated approval process The briefing book includes new post-hoc analyses of data from completed clinical trials and addresses comments made by the FDA during a previous meeting in late 2023 Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a…

Continue Reading

ThursdayJul 18, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Reveals Findings of Hyperion Research Quantum Optimization ROI Study and Announces Nomination for Technology Impact Awards

Majority of surveyed businesses actively engaged in quantum computing anticipate significant returns on investment (“ROI”) from their quantum optimization efforts Survey also highlights a significant increase in quantum adoption, with 21% of respondents either currently employing or planning to integrate quantum technology into production within the next 12 to 18 months D-Wave has been named a finalist in the GameChanger Ambition category of the upcoming Technology Impact Awards (“TIAs”) by the BC Tech Association D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the findings…

Continue Reading

WednesdayJul 17, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Issuance of Three New Patents, Growing Portfolio to 46 Granted Patents Worldwide

Considered intangible assets, patents offer a significant competitive advantage and value for companies Lexaria Bioscience views its growing patent portfolio as a solid foundation upon which to build future commercial partnerships The company recently announced the receipt of three new patents in the E.U., Canada, and the U.S. The issuance of the latest three patents grows Lexaria’s patent portfolio to 46 granted patents worldwide Lexaria’s multi-patented DehydraTECH(TM) “drug delivery platform technology” offers proven increased bioavailability, enhancing the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of…

Continue Reading

WednesdayJul 17, 2024 9:45 am

Torr Metals Inc. (TSX.V: TMET): Ontario’s Golden Past Hints at a Glittering Future

Ontario is renowned for world-class mining infrastructure and gold and copper deposits, with the world-class Timmins Gold Camp region hosting $400+ billion in gold resources Torr Metals is developing its 100% owned 261km2 Filion Gold Project, ideally located adjacent to the Trans-Canada Highway 11 and northwest of Timmins, with all requisite mining infrastructure Late last year Torr conducted the first large-scale systematic soil program ever conducted in the project area, with39 of 318 humus samples returning highly anomalous values greater than 10 parts per billion (ppb) gold and13 exceeding 20 ppb Au, reaching a maximum of 1,320 ppb Au The…

Continue Reading

WednesdayJul 17, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Files New Composition of Matter Patent for Buntanetap

Annovis has filed a new composition of matter patent with the U.S. Patent and Trademark Office covering novel solid forms of buntanetap, selecting the best crystal, and building upon the provisional patent filed in June 2023 The company's research focuses on inhibiting the production of multiple neurotoxic proteins that contribute to the progression of neurodegenerative diseases Annovis continues to expand its position in an ongoing fight against neurodegenerative diseases Annovis Bio (NYSE: ANVS), a pioneering biotechnology company, committed to addressing unmet medical needs through innovative research and development efforts, particularly in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, is…

Continue Reading

TuesdayJul 16, 2024 1:57 pm

QualityStocksNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Issues Update on SASB Program

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided an operational update for the SASB gas field well intervention program. “The fantastic response of South Akcakoca-2 once the water was lift off the perforations indicates that the reservoirs will produce the gas they contain once the water loading is removed,” said Arthur Halleran, CEO of Trillion. “The wells are going to be perforated and monitored during clean up to evaluate the reservoirs response. The next phase of this project is to install…

Continue Reading

TuesdayJul 16, 2024 11:15 am

Ensuring the Future of Your Digital Assets: Insights from the Digital Assets Protection Webinar

The Digital Assets Protection Webinar organized by Blockchain Legal Institute Inc. was held online on June 29, 2024, and covered the topic of safeguarding your Digital Assets & Legacy. The event was attended by traders, entrepreneurs, shareholders, enthusiasts, businesses dealing in digital assets, and those who have a keen interest in the subject. Digital asset organizations and investors took to the platform to connect with experts and engage in important topics that guide the digital assets world. The speaker's sessions were presided over by two esteemed dignitaries of the Digital assets realms, namely, Jacqueline Cooper, JD, CEO of the Blockchain…

Continue Reading

TuesdayJul 16, 2024 10:30 am

Artificial Intelligence takes Center Stage at Blockchain Futurist Conference 2024 in Toronto

The highly anticipated Blockchain Futurist Conference, Canada’s Largest Web3 Event, is set to return for its sixth year to Toronto this August 13-14, 2024, with a focus on Artificial Intelligence as a core theme. This year's event promises to offer sessions, panels, and sub-events centered around AI, highlighting how these technologies are transforming Web3 and reshaping our world. The dedicated AI segment is scheduled for Wednesday, August 14, 2024, and is accessible with all conference passes. AI and Web3 technologies are rapidly converging to create a future that promises to revolutionize the digital landscape. AI's ability to analyze vast amounts…

Continue Reading

TuesdayJul 16, 2024 9:45 am

GEMXX Corp. (GEMZ) Plans to Fully Harness Potential of Two Promising Target Basins in Latin America, Bolstered by Recent Strategic Addition to Primary Investment Target’s Board

GEMXX recently announced the addition of Ali S. Abood to the board of its primary investment target, Latin Energy Partners (“LEP”) The company signed in early June a definitive agreement with LEP to drill four test wells in a highly promising geological formation in Latin America GEMXX and LEP are joining forces to fully harness the potential of two target basins estimated to hold more than 1 billion barrels each of recoverable oil The strategic addition of Mr. Abood to LEP’s board aligns with its commitment to strengthening its investment portfolio and expanding its influence in the global energy sector…

Continue Reading

TuesdayJul 16, 2024 9:00 am

Software Effective Solutions Corp. (SFWJ) Strengthening Cannabis Foothold as CSA Status Set to Change

An overwhelming share of U.S. adults say marijuana should be legal for medical or recreational use, reports Pew Research Center The U.S. attorney general has submitted official notice to begin the process of moving marijuana from a Schedule 1 to Schedule 3 drug under the Controlled Substances Act MedCana is committed to building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts With a significant majority of Americans supporting cannabis use and the U.S. government on the verge of changing the status of the substance under the Controlled Substances Act (“CSA”), Software Effective Solutions (d/b/a MedCana)…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered